489 related articles for article (PubMed ID: 33995965)
1. The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection.
Jahani Sherafat S; Mokmeli S; Rostami-Nejad M; Razaghi Z; Rezaei Tavirani M; Razzaghi M
J Lasers Med Sci; 2020; 11(Suppl 1):S23-S29. PubMed ID: 33995965
[No Abstract] [Full Text] [Related]
2. Photobiomodulation Therapy as a Possible New Approach in COVID-19: A Systematic Review.
de Matos BTL; Buchaim DV; Pomini KT; Barbalho SM; Guiguer EL; Reis CHB; Bueno CRS; Cunha MRD; Pereira ESBM; Buchaim RL
Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34207199
[TBL] [Abstract][Full Text] [Related]
3. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70.
Kitchen LC; Berman M; Halper J; Chazot P
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563611
[TBL] [Abstract][Full Text] [Related]
4. A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19.
Sigman SA; Mokmeli S; Monici M; Vetrici MA
Am J Case Rep; 2020 Aug; 21():e926779. PubMed ID: 32865522
[TBL] [Abstract][Full Text] [Related]
5. Influence of photobiomodulation therapy on the treatment of pulmonary inflammatory conditions and its impact on COVID-19.
Macedo DB; Tim CR; Kido HW; Macedo JB; Martignago CCS; Renno ACM; Macedo GB; Assis L
Lasers Med Sci; 2022 Apr; 37(3):1921-1929. PubMed ID: 34694503
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
7. Photobiomodulation (PBMT) and antimicrobial photodynamic therapy (aPDT) in oral manifestations of patients infected by Sars-CoV-2: systematic review and meta-analysis.
Pacheco JA; Molena KF; Martins CROG; Corona SAM; Borsatto MC
Bull Natl Res Cent; 2022; 46(1):140. PubMed ID: 35601476
[TBL] [Abstract][Full Text] [Related]
8. Photobiomodulation Therapy (PBMT) Applied in Bone Reconstructive Surgery Using Bovine Bone Grafts: A Systematic Review.
Rosso MPO; Buchaim DV; Pomini KT; Coletta BBD; Reis CHB; Pilon JPG; Duarte Júnior G; Buchaim RL
Materials (Basel); 2019 Dec; 12(24):. PubMed ID: 31817369
[TBL] [Abstract][Full Text] [Related]
9. Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management.
Fekrazad R; Asefi S; Pourhajibagher M; Vahdatinia F; Fekrazad S; Bahador A; Abrahamse H; Hamblin MR
Adv Exp Med Biol; 2021; 1318():517-547. PubMed ID: 33973198
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
[TBL] [Abstract][Full Text] [Related]
11. Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19.
Mokmeli S; Vetrici M
Can J Respir Ther; 2020; 56():25-31. PubMed ID: 32844112
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.
Lin SH; Zhao YS; Zhou DX; Zhou FC; Xu F
Genes Dis; 2020 Dec; 7(4):520-527. PubMed ID: 32837983
[TBL] [Abstract][Full Text] [Related]
14. Photobiomodulation therapy as a high potential treatment modality for COVID-19.
Soheilifar S; Fathi H; Naghdi N
Lasers Med Sci; 2021 Jul; 36(5):935-938. PubMed ID: 33241526
[TBL] [Abstract][Full Text] [Related]
15. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Adjunctive Photobiomodulation (PBMT) for COVID-19 Pneumonia via Clinical Status and Pulmonary Severity Indices in a Preliminary Trial.
Vetrici MA; Mokmeli S; Bohm AR; Monici M; Sigman SA
J Inflamm Res; 2021; 14():965-979. PubMed ID: 33776469
[TBL] [Abstract][Full Text] [Related]
17. The immune system and COVID-19: Friend or foe?
Yazdanpanah F; Hamblin MR; Rezaei N
Life Sci; 2020 Sep; 256():117900. PubMed ID: 32502542
[TBL] [Abstract][Full Text] [Related]
18. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
Falcone C; Caracciolo M; Correale P; Macheda S; Vadalà EG; La Scala S; Tescione M; Danieli R; Ferrarelli A; Tarsitano MG; Romano L; De Lorenzo A
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967358
[TBL] [Abstract][Full Text] [Related]
19. Photobiomodulation therapy (PBMT) on acute pain and inflammation in patients who underwent total hip arthroplasty-a randomized, triple-blind, placebo-controlled clinical trial.
Langella LG; Casalechi HL; Tomazoni SS; Johnson DS; Albertini R; Pallotta RC; Marcos RL; de Carvalho PTC; Leal-Junior ECP
Lasers Med Sci; 2018 Dec; 33(9):1933-1940. PubMed ID: 29909435
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
